Showing results (251-260 of 296) with videos related to

Sort By:
Pageof 30
Contemporary Clinical Trials|July 15, 2018
The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trialRae Jean Proeschold-Bell, Donna M Evon, Christina Makarushka, et al.
Hepatology (Baltimore, Md.)|February 15, 2001
Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis CK R Reddy, T L Wright, P J Pockros, et al.
Contemporary Clinical Trials|March 27, 2017
Patient engagement and study design of PROP UP: A multi-site patient-centered prospective observational study of patients undergoing hepatitis C treatmentDonna M Evon, Carol E Golin, Paul Stewart, et al.
Journal of Clinical Gastroenterology|May 16, 2014
Sustained virologic response rates with telaprevir-based therapy in treatment-naive patients evaluated by race or ethnicitySteven L Flamm, Andrew J Muir, Michael W Fried, et al.
Hepatology Communications|October 9, 2019
Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV-TARGET AnalysisKavita Radhakrishnan, Adrian M Di Bisceglie, K Rajender Reddy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2017
An Efficient, Large-Scale Survey of Hepatitis C Viremia in the Democratic Republic of the Congo Using Dried Blood SpotsJonathan B Parr, Evans K Lodge, Vera Holzmayer, et al.
Journal of Clinical Pharmacology|October 21, 2009
Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis CRoy L Hawke, Sarah J Schrieber, Tedi A Soule, et al.
Lancet (London, England)|June 8, 2014
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trialIra M Jacobson, Gregory J Dore, Graham R Foster, et al.
Hepatology (Baltimore, Md.)|August 3, 2020
Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for InnovationElizabeth C Verna, Marina Serper, Jaime Chu, et al.
Alimentary Pharmacology & Therapeutics|January 29, 2015
Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevirR K Sterling, A Kuo, V K Rustgi, et al.
Pageof 30